Skip to content

Male Executives Control 99 Times More S&P 500 Shares Than Women

Gilead, Lilly Sue Natco to Block Copies of Zydelig Leukemia Drug

June 25, 2022 by COVER

June 24, 2022, 4:24 PM

Gilead Sciences Inc. and Eli Lilly & Co. allege that a generic version of Gilead’s Zydelig proposed by Natco Pharma Ltd. infringes five patents for the leukemia treatment, according to a federal lawsuit in Delaware.

Gilead Calistoga LLC owns three of the patents, and Gilead is the exclusive licensee of two others owned by Lilly’s ICOS Corp. unit, according to a complaint filed Thursday in the US District Court for the District of Delaware.

The Lilly patents expire in July 2025 and August 2025. Of the Gilead patents, two expire in March 2033, and one in September 2033, court …

Christopher Yasiejko

Correspondent

© 2022 The Bureau of National Affairs, Inc.

All Rights Reserved

Categories Breaking News

Post navigation

Boy, 4, given accidental vasectomy during hernia surgery, Texas lawsuit says – National

Burger King Employee of 27 Years Receives Over $50,000 in GoFundMe After Goodie Bag Video Goes Viral

Leave a Comment Cancel reply

Comment

Name Email Website

Save my name, email, and website in this browser for the next time I comment.

Notify me of follow-up comments by email.

Notify me of new posts by email.

Δ

Search

©2024 cover.notroop.com